← Leaderboards
Gwenn S Smith
Long Island Jewish Medical Center
$16,874,889
Attributed
$16,896,389
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–22$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$16,896,389 · 16
By mechanism
R01$14,715,267 · 6
P50$961,133 · 1
K02$884,365 · 1
M01$292,624 · 7
R13$43,000 · 1
Top collaborators
- Dean Foster Wong1 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPositron-Emission TomographySymptomsRadiotracerSerotoninGlucose MetabolismNeuroimagingNeurobiologyS DiseaseScanningBrainNormal AgingAnteriorSchizophreniaResolutionAmyloidPharmaceutical PreparationsNeuropathologyImpaired CognitionMouse ModelMild Cognitive ImpairmentDopaminePre-ClinicalIn Vivo
Grant awards (51)
Longitudinal Molecular Imaging of Neuropathology and Serotonin in Mild Cognitive Impairment$960,234
R01 · FY2022 · AG · contact PI
Longitudinal Molecular Imaging of Neuropathology and Serotonin in Mild Cognitive Impairment$960,234
R01 · FY2021 · AG · contact PI
Longitudinal Molecular Imaging of Neuropathology and Serotonin in Mild Cognitive Impairment$960,234
R01 · FY2020 · AG · contact PI
Longitudinal Molecular Imaging of Neuropathology and Serotonin in Mild Cognitive Impairment$960,250
R01 · FY2019 · AG · contact PI
Longitudinal Molecular Imaging of Neuropathology and Serotonin in Mild Cognitive Impairment$975,825
R01 · FY2018 · AG · contact PI
Longitudinal imaging of neuropsychiatric symptoms in mild cognitive impairment$566,999
R01 · FY2015 · AG · contact PI
Longitudinal imaging of neuropsychiatric symptoms in mild cognitive impairment$585,588
R01 · FY2014 · AG · contact PI
PET Studies of Serotonin and Amyloid in MCI$583,276
R01 · FY2014 · AG · contact PI
Geriatric Depression: PET Studies of Pathophysiology and Treatment Response$656,190
R01 · FY2013 · MH · contact PI
PET Studies of Serotonin and Amyloid in MCI$564,125
R01 · FY2013 · AG · contact PI
Longitudinal imaging of neuropsychiatric symptoms in mild cognitive impairment$493,576
R01 · FY2013 · AG · contact PI
Geriatric Depression: PET Studies of Pathophysiology and Treatment Response$682,627
R01 · FY2012 · MH · contact PI
PET Studies of Serotonin and Amyloid in MCI$593,446
R01 · FY2012 · AG · contact PI
Longitudinal imaging of neuropsychiatric symptoms in mild cognitive impairment$493,764
R01 · FY2012 · AG · contact PI
Striatal D2/D3 Dopamine receptor availability in first episode schizophrenia$167,970
P50 · FY2012 · MH · contact PI
Striatal D2/D3 Dopamine receptor availability in first episode schizophrenia$79,080
P50 · FY2012 · MH · contact PI
Striatal D2/D3 Dopamine receptor availability in first episode schizophrenia$36,582
P50 · FY2012 · MH · contact PI
Geriatric Depression: PET Studies of Pathophysiology and Treatment Response$687,223
R01 · FY2011 · MH · contact PI
PET Studies of Serotonin and Amyloid in MCI$617,426
R01 · FY2011 · AG · contact PI
Longitudinal imaging of neuropsychiatric symptoms in mild cognitive impairment$505,233
R01 · FY2011 · AG · contact PI
Striatal D2/D3 Dopamine receptor availability in first episode schizophrenia$169,264
P50 · FY2011 · MH · contact PI
9 Intl Symposium - Functional Neuroreceptor Mapping of the Living Brain NRM 2012$43,000
R13 · FY2011 · MH
Geriatric Depression: PET Studies of Pathophysiology and Treatment Response$716,137
R01 · FY2010 · MH · contact PI
Striatal D2/D3 Dopamine receptor availability in first episode schizophrenia$170,730
P50 · FY2010 · MH · contact PI
Striatal D2/D3 Dopamine receptor availability in first episode schizophrenia$168,766
P50 · FY2009 · MH · contact PI
Striatal D2/D3 Dopamine receptor availability in first episode schizophrenia$168,741
P50 · FY2008 · MH · contact PI
Monoamiergic Function in Geriatric Psychiatry$89,214
K02 · FY2008 · MH · contact PI
Monoamiergic Function in Geriatric Psychiatry$124,416
K02 · FY2007 · MH · contact PI
THE EVALUATION OF THE CLINICAL AND GLUCOSE METABOLIC RESPONSE TO ANTIDEPRESSA$8,790
M01 · FY2007 · RR · contact PI
Serotonin Modulation in Geriatric Depression$378,369
R01 · FY2006 · MH · contact PI
Monoamiergic Function in Geriatric Psychiatry$123,549
K02 · FY2006 · MH · contact PI
Serotonin Modulation in Geriatric Depression$88,068
R01 · FY2006 · MH · contact PI
THE EVALUATION OF THE CLINICAL AND GLUCOSE METABOLIC RESPONSE TO ANTIDEPRESSA$14,666
M01 · FY2006 · RR · contact PI
POSITRON EMISSION TOMOGRAPHY (PET) STUDIES OF CHOLINERGIC MODULATION IN ALZHEIME$13,124
M01 · FY2006 · RR · contact PI
DOPAMINE FUNCTION AND CEREBRAL GLUCOSE METABOLISM IN PSYCHOTIC DEPRESSION$4,632
M01 · FY2006 · RR · contact PI
Serotonin Modulation in Geriatric Depression$1
R01 · FY2006 · MH · contact PI
Serotonin Modulation in Geriatric Depression$463,812
R01 · FY2005 · MH
Monoamiergic Function in Geriatric Psychiatry$119,950
K02 · FY2005 · MH
THE EVALUATION OF THE CLINICAL AND GLUCOSE METABOLIC RESPONSE TO ANTIDEPRESSA$74,520
M01 · FY2005 · RR
POSITRON EMISSION TOMOGRAPHY (PET) STUDIES OF CHOLINERGIC MODULATION IN ALZHEIME$9,804
M01 · FY2005 · RR
SEROTONIN MODULATION OF DOPAMINE STUDIED WITH POSITRON EMMISSION TOMOGRAPHY(PET)$2,942
M01 · FY2005 · RR
Serotonin Modulation in Geriatric Depression$450,396
R01 · FY2004 · MH
Metabolic Response to Antidepressants$143,041
M01 · FY2004 · RR
Monoamiergic Function in Geriatric Psychiatry$116,456
K02 · FY2004 · MH
PET Studies of Cholinergic Modulation in Alzheimer's$14,070
M01 · FY2004 · RR
Serotonin Modulation of Dopamine Studied with PET$7,035
M01 · FY2004 · RR
Serotonin Modulation in Geriatric Depression$479,485
R01 · FY2003 · MH
MONOAMINERGIC FUNCTION IN GERIATRIC NEUROPSYCHIATRY$103,679
K02 · FY2002 · MH
MONOAMINERGIC FUNCTION IN GERIATRIC NEUROPSYCHIATRY$103,679
K02 · FY2001 · MH
PET STUDIES OF CHOLINERGIC MODULATION IN ALZHEIMERS$292,749
R01 · FY2000 · MH
MONOAMINERGIC FUNCTION IN GERIATRIC NEUROPSYCHIATRY$103,422
K02 · FY2000 · MH